Simplex Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $965K | Sell |
4,300
-1,700
| -28% | -$424K | ﹤0.01% | 2533 |
|
|
2025
Q4 | $1.45M | Sell |
6,000
-9,300
| -61% | -$2.38M | ﹤0.01% | 2247 |
|
|
2025
Q3 | $4.19M | Buy |
15,300
+4,300
| +39% | +$1.17M | ﹤0.01% | 1638 |
|
|
2025
Q2 | $2.84M | Sell |
11,000
-1,200
| -10% | -$286K | ﹤0.01% | 1807 |
|
|
2025
Q1 | $2.73M | Sell |
12,200
-4,100
| -25% | -$957K | ﹤0.01% | 1749 |
|
|
2024
Q4 | $3.73M | Sell |
16,300
-36,900
| -69% | -$8.88M | ﹤0.01% | 1694 |
|
|
2024
Q3 | $13M | Sell |
53,200
-18,100
| -25% | -$4.04M | 0.01% | 874 |
|
|
2024
Q2 | $13.6M | Buy |
71,300
+42,600
| +148% | +$8.64M | 0.01% | 811 |
|
|
2024
Q1 | $5.68M | Buy |
28,700
+2,700
| +10% | +$495K | ﹤0.01% | 1514 |
|
|
2023
Q4 | $4.47M | Sell |
26,000
-34,300
| -57% | -$5.27M | ﹤0.01% | 1657 |
|
|
2023
Q3 | $8.92M | Buy |
60,300
+56,600
| +1,530% | +$10.2M | 0.01% | 984 |
|
|
2023
Q2 | $808K | Buy |
3,700
+3,100
| +517% | +$691K | ﹤0.01% | 2808 |
|
|
2023
Q1 | $131K | Sell |
600
-800
| -57% | -$174K | ﹤0.01% | 4849 |
|
|
2022
Q4 | $291K | Sell |
1,400
-14,200
| -91% | -$3.12M | ﹤0.01% | 3778 |
|
|
2022
Q3 | $3.4M | Buy |
15,600
+6,600
| +73% | +$1.5M | ﹤0.01% | 1498 |
|
|
2022
Q2 | $1.89M | Buy |
9,000
+1,900
| +27% | +$404K | ﹤0.01% | 1945 |
|
|
2022
Q1 | $1.72M | Buy |
7,100
+6,600
| +1,320% | +$1.6M | ﹤0.01% | 2264 |
|
|
2021
Q4 | $130K | Sell |
500
-14,200
| -97% | -$3.68M | ﹤0.01% | 5836 |
|
|
2021
Q3 | $3.64M | Buy |
14,700
+4,100
| +39% | +$1.12M | ﹤0.01% | 1491 |
|
|
2021
Q2 | $2.61M | Buy |
10,600
+10,512
| +11,945% | +$2.21M | ﹤0.01% | 1830 |
|
|
2021
Q1 | $1.71M | Sell |
88
-115
| -57% | -$23.1K | ﹤0.01% | 1788 |
|
|
2020
Q4 | $4.31M | Sell |
203
-72
| -26% | -$14.4K | 0.01% | 1086 |
|
|
2020
Q3 | $4.71M | Buy |
275
+169
| +159% | +$31.2K | 0.01% | 903 |
|
|
2020
Q2 | $2.04M | Sell |
106
-338
| -76% | -$55.3K | ﹤0.01% | 1493 |
|
|
2020
Q1 | $6.54M | Buy |
444
+42
| +10% | +$6.69K | 0.01% | 564 |
|
|
2019
Q4 | $6.23M | Sell |
402
-34
| -8% | -$4.9K | 0.01% | 670 |
|
|
2019
Q3 | $5.89M | Buy |
436
+178
| +69% | +$23.3K | 0.02% | 634 |
|
|
2019
Q2 | $3.15M | Sell |
258
-184
| -42% | -$20.4K | 0.01% | 980 |
|
|
2019
Q1 | $4.59M | Buy |
442
+222
| +101% | +$22.9K | 0.01% | 741 |
|
|
2018
Q4 | $2.5M | Buy |
220
+189
| +610% | +$20.3K | 0.01% | 948 |
|
|
2018
Q3 | $357K | Buy |
31
+19
| +158% | +$2.08K | ﹤0.01% | 2968 |
|
|
2018
Q2 | $124K | Sell |
12
-82
| -87% | -$8.3K | ﹤0.01% | 4041 |
|
|
2018
Q1 | $63K | Buy |
94
+30
| +47% | +$2.83K | ﹤0.01% | 2206 |
|
|
2017
Q4 | $7K | Buy |
+64
| New | +$5.29K | ﹤0.01% | 4219 |
|
|
2017
Q3 | – | Sell |
-227
| Closed | -$3K | – | 6518 |
|
|
2017
Q2 | $3K | Buy |
227
+199
| +711% | +$14.2K | ﹤0.01% | 5021 |
|
|
2017
Q1 | $6K | Sell |
28
-213
| -88% | -$14.7K | ﹤0.01% | 4465 |
|
|
2016
Q4 | $60K | Sell |
241
-42
| -15% | -$2.57K | ﹤0.01% | 1984 |
|
|
2016
Q3 | $13K | Buy |
283
+208
| +277% | +$13.8K | ﹤0.01% | 3390 |
|
|
2016
Q2 | $15K | Buy |
75
+16
| +27% | +$943 | ﹤0.01% | 3176 |
|
|
2016
Q1 | $2K | Sell |
59
-83
| -58% | -$4.7K | ﹤0.01% | 4791 |
|
|
2015
Q4 | $6K | Sell |
142
-4
| -3% | -$225 | ﹤0.01% | 3765 |
|
|
2015
Q3 | $10K | Buy |
146
+134
| +1,117% | +$7.21K | ﹤0.01% | 3451 |
|
|
2015
Q2 | $2K | Sell |
12
-129
| -91% | -$8.14K | ﹤0.01% | 4338 |
|
|
2015
Q1 | $81K | Buy |
+141
| New | +$9.16K | 0.01% | 1227 |
|
Other funds holding RMD
VCM
VPM
DAM
Simplex Trading's RMD Position: Q2 2024 in Review
Simplex Trading sold out of ResMed (RMD) in Q2 2024, closing a stake of 7,430 shares — an estimated $1.51M sold.
Simplex Trading first reported a position in RMD in Q4 2014 and held it in 15 quarters. The position peaked at $2.03M in Q4 2021. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.
- Simplex Trading reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
- Simplex Trading sold 7,430 ResMed shares in Q2 2024, an estimated $1.51M.
- Simplex Trading first reported a position in ResMed in Q4 2014 and held it in 15 quarters.
- Simplex Trading's ResMed position peaked at $2.03M in Q4 2021.
- 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.
Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.